These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3737462)

  • 1. [The oral ursodeoxycholic acid test and its value in the diagnosis of liver diseases].
    Goszcz A
    Pol Tyg Lek; 1986 Apr; 41(17):547-51. PubMed ID: 3737462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance and limitations of oral UDCA loading in liver function test].
    Matsuzaki Y; Osuga T; Shoda J; Imawari M; Mitamura K
    Nihon Rinsho; 1984 Jul; 42(7):1671-6. PubMed ID: 6492410
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.
    Ohkubo H; Okuda K; Iida S; Ohnishi K; Ikawa S; Makino I
    Gastroenterology; 1984 Mar; 86(3):514-20. PubMed ID: 6693014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical significance of oral ursodeoxycholic acid tolerance test for patients with hepatobiliary diseases by using radioimmunoassay (author's transl)].
    Shinozaki K
    Rinsho Byori; 1981 May; 29(5):475-7. PubMed ID: 7289113
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
    Yamashita Y; Moriyasu F; Kimura T; Ono S; Kawasaki T; Tamada T; Ban N; Nakamura T; Uchino H
    Nihon Shokakibyo Gakkai Zasshi; 1988 Dec; 85(12):2651-7. PubMed ID: 3244182
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bile acids in chronic hepatopathies].
    Luciani A; Massari M; Montanari P; Nora A; Zandomeneghi R
    Minerva Med; 1986 Dec; 77(49-50):2287-92. PubMed ID: 3808385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
    Raedsch R; Stiehl A; Hopf U; Möller B
    Z Gastroenterol Verh; 1989 Jul; 24():125-7. PubMed ID: 2474923
    [No Abstract]   [Full Text] [Related]  

  • 8. Can serum bile acid determination substitute BSP loading test in detecting and monitoring chronic liver diseases?
    Mazzanti R; Chiarantini E; Baronti E; Moscarella S; Arena U; Buzzelli G
    Boll Soc Ital Biol Sper; 1986 Feb; 62(2):219-26. PubMed ID: 3087392
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum levels of bile salts in the diagnosis of chronic liver diseases].
    Testa R; Bocchini R; Dellepiane F; Mansi C; Picciotto A; Savarino V; Celle G
    Pathologica; 1979; 71(1016):823-8. PubMed ID: 262296
    [No Abstract]   [Full Text] [Related]  

  • 10. [Change of serum bile acids levels after administration of UDCA and test meals (author's transl)].
    Inaguma H
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):289. PubMed ID: 7098117
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey.
    Sarva RP; Fromm H; Farivar S; Sembrat RF; Mendelow H; Shinozuka H; Wolfson SK
    Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of serum bile acids in chronic diseases of the liver].
    Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
    Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1980 Feb; 78(2):214-9. PubMed ID: 7350042
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
    Whiting MJ; Watts JM
    Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
    [No Abstract]   [Full Text] [Related]  

  • 17. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.